A NEW meta analysis study from
researchers at the University of
Auckland concluded that calcium
supplements may increase the risk
of cardiovascular events.
Researchers looked at 15 patientlevel
and trial-level studies of
patients aged 40 years and over,
who were either administered with
under 500mg of calcium supplements
per day or a placebo over periods
of more than one year.
Analysis of the prior studies, as
well as hospital admissions and
death certificates, found that calcium
supplements without Vitamin D
were associated with an increased
risk of myocardial infarction.
“As calcium supplements are
widely used these modest increases
in risk of cardiovascular disease
might translate into a large burden
of disease in the population,” the
researchers said.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jul 10
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.